Johnson & Johnson to test experimental HIV vaccine in US, Europe

Johnson & Johnson to test experimental HIV vaccine in US, Europe

Johnson & Johnson said on Friday it plans to conduct a late-stage study of its investigational vaccine for Human Immunodeficiency Virus (HIV) in several countries across the Americas and Europe, including the United States.

The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid

REUTERS: Johnson & Johnson said on Friday it plans to conduct a late-stage study of its investigational vaccine for Human Immunodeficiency Virus (HIV) in several countries across the Americas and Europe, including the United States.

The drugmaker already has a mid-stage HIV vaccine study underway in five southern African countries.

There are currently no vaccines for HIV, a virus that weakens the body's immune system.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)

Source: Reuters

Bookmark